Final Scientific Program Now Live – Join Us in Singapore for Neuro Care 2026

We are pleased to announce that the Final Program is now live for the upcoming joint international conferences organized by Mathews Conferences. This prestigious event brings together two leading global meetings focused on advancing research and clinical practice in brain and mental health sciences.

Joint Conferences

• International Conference on Addiction Medicine, Mental Health and Psychiatry
• International Conference on Neurology and Neuroscience

These conferences will bring together neurologists, psychiatrists, neuroscientists, mental health professionals, researchers, clinicians, and healthcare innovators from around the world to share groundbreaking research, emerging therapies, and innovative clinical practices.

Event Details

📅 Dates: March 23–25, 2026
📍 Location: Singapore
🏨 Venue: Village Hotel Changi

The conference will be conducted in a hybrid format, allowing participants to attend in person in Singapore or virtually from anywhere across the globe.

What to Expect

The final program features a comprehensive lineup of:

• Keynote presentations by leading experts

• Oral and poster research sessions

• Discussions on emerging neuroscience and psychiatric treatments

• Networking opportunities with global professionals

• Collaborative sessions on addiction medicine and mental health care

Participants will gain valuable insights into recent developments in neurology, neuroscience, psychiatry, addiction medicine, and mental health research, fostering interdisciplinary collaboration and knowledge exchange.

Register Now

We invite researchers, academicians, clinicians, and healthcare professionals to explore the final program and secure their participation in this global scientific gathering.

🔗 Register Here: https://neurocareconference.com/register

Be part of this important international platform dedicated to advancing brain health, neuroscience innovation, and mental health research.

#Neurology #Neuroscience #MentalHealth #Psychiatry #AddictionMedicine #BrainHealth #NeuroScienceConference #MentalHealthConference #MedicalResearch #HealthcareInnovation #GlobalResearch #SingaporeConference #Neurocare2026

🧠 Advancing Alzheimer’s Research: Exploring Potential Disease-Modifying Treatments

Presenter: Tamas Fulop (Université de Sherbrooke, Canada)
Presentation Type: Oral Presentation (Virtual)
Title: Potential disease-modifying treatments for neurocognitive disorders

---

🔬 Presentation Highlights

∙ Focus: Investigating innovative therapeutic strategies for Alzheimer's disease, one of the most challenging global neurodegenerative disorders.
∙ Clinical Challenge: Despite recent monoclonal antibody therapies, reliable disease-modifying treatments remain limited.
∙ Research Approach: Evaluation of existing drugs for repurposing in modulating key pathological hallmarks of Alzheimer’s disease.
∙ Drugs Studied: The anti-retroviral drug Raltegravir and SGLT2 inhibitors such as Empagliflozin and Dapagliflozin.
∙ Cellular Models: Experiments conducted using H4 neuroglioma and HMC3 microglia cell models to study molecular alterations induced by amyloid-beta.
∙ Key Findings:

• Raltegravir significantly reduced Tau phosphorylation (p-Tau181) and modulated key kinases and phosphatases.

• Reduced inflammatory signaling through downregulation of the NLRP3 inflammasome pathway.

• SGLT2 inhibitors decreased oxidative stress and neuroinflammatory responses triggered by amyloid-beta.
  ∙ Neuroprotective Effects: Gliflozins improved cell viability and reduced apoptosis in neuronal models.
  ∙ Therapeutic Potential: These findings suggest promising drug-repurposing strategies for modifying disease progression in Alzheimer’s disease.
  ∙ Research Outlook: Provides preliminary mechanistic insights supporting further clinical exploration of these treatments.

---

🌍 Join the Conference

Event: International Conference on Neurology and Neuroscience
📅 March 23–25, 2026
📍 Singapore & Online

🌐 Event Website: https://neurocareconference.com/
🧬 Submit Abstract: https://neurocareconference.com/abstract-submission
📝 Register: https://neurocareconference.com/register

---

💬 Connect with Global Experts in Neuroscience and Neurology to Explore the Latest Research, Innovations, and Clinical Advances.

#Neurology #Neuroscience #AlzheimersResearch #NeurodegenerativeDiseases #BrainHealth #CognitiveDisorders #NeuroscienceConference #NeurologyConference #MedicalResearch #BrainScience #NeuroInnovation #Neurocare2026 #SingaporeConference #HealthcareInnovation #GlobalResearch #ScientificConference 🧠🔬

🧠 Advancing Stroke Therapy: Mechanisms and Clinical Evidence of Mexidol® in Ischemic Stroke

Presenter: Aleksey Shchulkin – Ryazan State Medical University, Russian Federation
Presentation Type: Oral Presentation (In-Person)
Title: Ethylmethylhydroxypyridine succinate (Mexidol®): Mechanisms and clinical evidence in ischemic stroke

---

🔬 Presentation Highlights

∙ Therapeutic Focus: Exploration of Ethylmethylhydroxypyridine succinate (Mexidol®) as a neuroprotective treatment for ischemic stroke.

∙ Antioxidant Activity: The compound neutralizes superoxide radicals and enhances antioxidant enzyme activity including superoxide dismutase and glutathione peroxidase while activating the NRF2 transcription factor.

∙ Hypoxia Protection: Supports mitochondrial respiratory chain activity under low oxygen conditions and activates the succinate receptor (SUCNR1) while influencing the HIF-1α transcription factor, improving cellular resistance to hypoxia.

∙ Neuroprotective Effects: Experimental studies demonstrate reduction of neuroinflammation and apoptosis while promoting neuroplasticity, which is critical for brain recovery after stroke.

∙ Preclinical Evidence: Animal studies modeling acute focal cerebral stroke showed significant improvement in neurological symptoms and reduction in hemorrhagic lesion size in treated groups compared with placebo.

∙ Clinical Trial Results: A double-blind placebo-controlled MIR study involving 304 ischemic stroke patients demonstrated:

• Significant reduction in disability using the mRS scale

• Improved neurological function measured by NIHSS

• Enhanced mobility via the Rivermead Index

• Trends toward cognitive improvement assessed by the MoCA test

∙ Safety Profile: Adverse events were comparable between drug and placebo groups, confirming long-term safety and tolerability of sequential therapy.

∙ Clinical Impact: Findings highlight Mexidol® as a promising therapeutic strategy for improving neurological recovery and functional outcomes in ischemic stroke patients.

---

👨‍⚕️ About the Speaker

Dr. Aleksey Shchulkin is a Professor in the Department of Pharmacology and Head of the Pharmacokinetics Laboratory at Ryazan State Medical University, Russia.

∙ Expert in pharmacokinetics and neuroprotection
∙ Leading research in drug mechanisms and therapeutic interventions for neurological disorders
∙ Active contributor to experimental and clinical studies focused on stroke therapy and neuroprotective pharmacology

---

🔗 Join the Conference

Event: International Conference on Neurology and Neuroscience
📅 March 23–25, 2026
📍 Singapore & Online

🌐 Event Website: https://neurocareconference.com/
🧬 Submit Abstract: https://neurocareconference.com/abstract-submission
📝 Register: https://neurocareconference.com/register

Connect with global neurologists, neuroscientists, clinicians, and researchers to explore the latest innovations in brain science, stroke therapy, neurodegeneration, and neurological care.

---

#Neurology #Neuroscience #StrokeResearch #IschemicStroke #Neuroprotection #Pharmacology #BrainHealth #NeuroScienceConference #NeurologyConference #ClinicalResearch #MedicalInnovation #StrokeTreatment #Neuropharmacology #BrainResearch #HealthcareInnovation #SingaporeConference #NeuroCare2026

International Conference on Neurology and Neuroscience 2026 | Singapore & Online

The International Conference on Neurology and Neuroscience is set to take place on March 23–25, 2026 in Singapore & Online, bringing together leading neurologists, neuroscientists, researchers, clinicians, and healthcare innovators from around the world.

This global Neurology Conference 2026 will serve as a premier platform to discuss the latest advancements in brain research, neurological disorders, neuroimaging, neurogenetics, neurosurgery, neuroimmunology, and AI-driven innovations in neuroscience.

🧠 Conference Highlights

• Clinical Neurology & Neurophysiology

• Neurological Diseases & Brain Disorders

• Neuroimmunology & Neuroinflammation

• Neuroimaging & Diagnostic Technologies

• Neurosurgery & Therapeutic Innovations

• Pain Management & Neuropathic Pain

• Clinical Trials in Neurology

• AI in Neuroscience & Digital Neurology

Participants will gain access to high-impact keynote sessions, oral and poster presentations, networking opportunities, and cutting-edge discussions shaping the future of brain health and neurological care.

📅 Event Details

🌐 Website: https://neurocareconference.com/
🧬 Submit Abstract: https://neurocareconference.com/abstract-submission
📝 Register Now: https://neurocareconference.com/register

Join us in advancing innovation in neurology, neuroscience research, and brain health technologies.

#NeurologyConference #Neuroscience2026 #BrainResearch #ClinicalNeurology #NeuroCare2026 #DigitalNeurology #AIinHealthcare #SingaporeConference #HybridConference #BrainHealth

Final Call to Confirm Your Slot – Neurology and Neuroscience 2026

We are in the final stage of program preparation for the International Conference on Neurology and Neuroscience, scheduled for March 23–25, 2026 | Singapore & Online.

Our scientific agenda is being finalized, and session schedules are now being structured.

🔔 If you have not yet confirmed your participation, this is your final reminder.

To ensure your presentation is included in the official program, kindly confirm your slot at the earliest.

Why Confirm Now?

✔ Secure your speaking/presentation schedule
✔ Ensure inclusion in the final scientific program
✔ Avoid last-minute adjustments
✔ Receive official confirmation and event updates

📝 Confirm & Register: https://neurocareconference.com/register
🌐 Event Website: https://neurocareconference.com/

We look forward to your confirmation and to welcoming you to this global neurology gathering.

#NeurologyConference #Neuroscience2026 #FinalCall #ConfirmYourSlot #ScientificProgram #NeuroCare2026 #BrainResearch #HybridConference #SingaporeConference

🧠 Explore the Scientific Sessions – International Conference on Neurology and Neuroscience 2026

The International Conference on Neurology and Neuroscience is set to take place on March 23–25, 2026 | Singapore & Online, bringing together global leaders in neurology, neuroscience, and brain research.

This highly anticipated Neurology Conference 2026 will feature diverse and in-depth scientific sessions designed to highlight the latest advancements in clinical practice, research innovation, and neurotechnology.

---

🔬 Scientific Sessions Include:

1. Clinical Neurology and Neurophysiology

2. Neurological Diseases and Disorders

3. Neuroimmunology and Neuroinflammation

4. Neuroimaging and Diagnostic Techniques

5. Treatments and Therapeutic Approaches

6. Neurosurgery and Surgical Advances

7. Pain Management and Neuropathic Pain

8. Neurogenetics and Genomics

9. Case Reports and Clinical Observations

10. Clinical Trials in Neurology

These sessions will focus on emerging trends in brain health, neurological disorders, neurogenetics, digital neurology, AI in neuroscience, neuroimaging advancements, and innovative therapeutic strategies.

---

🌍 Why Participate?

• Present your latest neuroscience research

• Connect with international neurology experts

• Learn about breakthroughs in neurotechnology and precision medicine

• Engage in discussions on AI-driven neurological care

• Experience a flexible hybrid conference format

Whether you attend in Singapore or join virtually, this conference offers an excellent opportunity to expand your professional network and stay at the forefront of neurological science.

---

🌐 Website: https://neurocareconference.com/
🧬 Abstract Submission: https://neurocareconference.com/abstract-submission
📝 Register Here: https://neurocareconference.com/register

Join us to advance innovation in neurology, neuroscience research, clinical neurology, and brain disorder treatment.

#NeurologyConference #Neuroscience2026 #BrainResearch #ClinicalNeurology #Neuroimaging #Neurogenetics #NeuroCare2026 #DigitalNeurology #AIinHealthcare #Neurosurgery #PainManagement #Neuropsychiatry #SingaporeConference #HybridEvent

🌍 Neuro Care-2026 Early Bird Deadline Approaching – Register Now

 Early Bird Registration for the International Conference on Neurology and Neuroscience is closing very soon. Register now to take advantage of special discounted rates and secure your participation in this premier global scientific event.

The conference will be held on March 23–25, 2026, in Singapore and Online, bringing together neurologists, neuroscientists, clinicians, researchers, academicians, and healthcare professionals from around the world.

🌟 Benefits of Early Bird Registration

• Reduced registration fees

• Option to attend In-Person or Online

• Access to scientific sessions, keynote talks, and workshops

• Global networking and collaboration opportunities

• Conference certification and international exposure

🧠 Scientific Focus Areas

• Clinical Neurology and Neuroscience

• Neurophysiology and Neurodiagnostics

• Brain Disorders and Neurodegenerative Diseases

• Cognitive Neuroscience and Mental Health

• Stroke, Epilepsy, and Neuromuscular Disorders

🔗 Important Links

📝 Register Now: https://neurocareconference.com/register
🌐 Conference Website: https://neurocareconference.com/
📩 Contact Email: neurology@mathewsconference.com

Don’t miss this opportunity—register early and save while securing your place at Neurology and Neuroscience 2026.

#NeurologyConference #Neuroscience #EarlyBirdRegistration